Literature DB >> 13129656

Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia.

Brian Dean1, Simon M Laws, Eugene Hone, Kevin Taddei, Elizabeth Scarr, Elizabeth A Thomas, Clive Harper, Catriona McClean, Colin Masters, Nicola Lautenschlager, Samuel E Gandy, Ralph N Martins.   

Abstract

BACKGROUND: It is unclear whether altered expression of a specific isoform of apolipoprotein E (apoE) is associated with the pathology of schizophrenia.
METHODS: To address whether apoE may be involved in the pathology of schizophrenia, we measured the genotypic and allelic frequency of polymorphisms in its gene and transcriptional regulatory region in DNA from Brodmann's area (BA) 9 obtained postmortem from schizophrenic and control subjects as well as its levels in the same tissue using Western blot analysis.
RESULTS: The genotypic or allelic frequencies of any polymorphism studied did not vary between diagnostic cohorts. There was a significant increase in the levels of apoE protein in BA 9 from the schizophrenic subjects (Mean +/- SEM: 270 +/- 8.3 vs. 238 +/- 7.1 ng apoE/mg protein, p =.008) and a decrease in tissue from an analogous cortical region from rats treated with haloperidol compared with vehicle-treated animals (50 +/- 6.4 vs. 116 +/- 9.2 ng apoE/mg protein; p =.0002).
CONCLUSIONS: These data support the hypothesis that increased levels of apoE may be associated with the pathology of schizophrenia and that antipsychotic drugs decrease apoE levels as part of their therapeutic actions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13129656     DOI: 10.1016/s0006-3223(03)00075-1

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  13 in total

Review 1.  Cell-specific production, secretion, and function of apolipoprotein E.

Authors:  Maaike Kockx; Mathew Traini; Leonard Kritharides
Journal:  J Mol Med (Berl)       Date:  2018-03-07       Impact factor: 4.599

Review 2.  Is there evidence for late cognitive decline in chronic schizophrenia?

Authors:  Jharna N Shah; Salah U Qureshi; Ali Jawaid; Paul E Schulz
Journal:  Psychiatr Q       Date:  2012-06

3.  ApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotype.

Authors:  Fidel Vila-Rodriguez; William G Honer; Sheila M Innis; Cheryl L Wellington; Clare L Beasley
Journal:  J Psychiatry Neurosci       Date:  2011-01       Impact factor: 6.186

4.  Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients.

Authors:  Y J La; C L Wan; H Zhu; Y F Yang; Y S Chen; Y X Pan; G Y Feng; L He
Journal:  J Neural Transm (Vienna)       Date:  2006-12-14       Impact factor: 3.575

5.  Apolipoprotein E polymorphism is associated with age of onset in schizophrenia.

Authors:  Olli Kampman; Sami Anttila; Ari Illi; Kari M Mattila; Riikka Rontu; Esa Leinonen; Terho Lehtimäki
Journal:  J Hum Genet       Date:  2004-06-18       Impact factor: 3.172

6.  Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spots.

Authors:  Jason D Cooper; Sureyya Ozcan; Renee M Gardner; Nitin Rustogi; Susanne Wicks; Geertje F van Rees; F Markus Leweke; Christina Dalman; Håkan Karlsson; Sabine Bahn
Journal:  Transl Psychiatry       Date:  2017-12-18       Impact factor: 6.222

7.  Low Density Lipoprotein Receptor-Related Protein and Apolipoprotein E Expression is Altered in Schizophrenia.

Authors:  Andrew Stuart Gibbons; Elizabeth A Thomas; Elizabeth Scarr; Brian Dean
Journal:  Front Psychiatry       Date:  2010-07-08       Impact factor: 4.157

Review 8.  Genetics in schizophrenia: where are we and what next?

Authors:  Arun K Tiwari; Clement C Zai; Daniel J Müller; James L Kennedy
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

9.  Psychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells.

Authors:  Audun O Vik-Mo; Johan Fernø; Silje Skrede; Vidar M Steen
Journal:  BMC Pharmacol       Date:  2009-08-29

10.  Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis.

Authors:  Saeed Mohammad Al-Asmary; Saeed Kadasah; Misbahul Arfin; Mohammad Tariq; Abdulrahman Al-Asmari
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.